NASDAQ · Drug Manufacturers - Specialty & Generic

ANIP (ANIP) Stock

$82.63 +3.44% NASDAQ: ANIP Healthcare

Valuation

MetricValue
Price$82.63
Market Cap$1.88B
P/E Ratio24.92
P/B Ratio3.48
P/S Ratio2.04
EPS (TTM)$0.00
52-Week High$99.50
52-Week Low$56.71
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE14.42%
ROA5.42%
ROCE15.00%
Gross Margin9.17%
Operating Margin9.17%
Net Margin9.71%
Debt/Equity0.58
Current Ratio2.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$216.0M$316.0M$487.0M$614.0M$883.0M
Operating Profit$-40.0M$-35.0M$47.0M$1.0M$81.0M
Net Profit$-43.0M$-48.0M$19.0M$-19.0M$78.0M
EPS$-3.40$-3.05$0.94$-1.04$3.32
Op Margin-18.4%-11.2%9.7%0.1%9.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$772.0M$760.0M$904.0M$1.3B$1.4B
Total Liabilities$413.0M$422.0M$447.0M$855.0M$900.0M
Cash$100.0M$48.0M$221.0M$145.0M$286.0M
Borrowings$287.0M$287.0M$286.0M$624.0M$325.0M

Latest News

2 Value Stocks for Long-Term Investors and 1 We Avoid StockStory · Jul 10, 2026 ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge Motley Fool · Jul 9, 2026 3 of Wall Street’s Favorite Stocks to Target This Week StockStory · Jul 6, 2026 How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks? Barchart · Jun 19, 2026 Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings? Zacks · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$3.0M$-31.0M$119.0M$64.0M$185.0M
Investing Cash Flow$-129.0M$-32.0M$-37.0M$-422.0M$-48.0M
Financing Cash Flow$1.0M$-1.0M$-8.0M$-79.0M$-12.0M
Net Cash Flow$92.0M$-52.0M$168.0M$-76.0M$141.0M
Free Cash Flow$-20.0M$-48.0M$100.0M$47.0M$171.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA11.16
FCF Yield8.81%
Quick Ratio2.52
Interest Coverage4.05
Return 1Y17.73%
Return 3Y49.19%
Return 5Y137.73%

Ownership

Insiders Held5.55%
Institutions Held110.29%
Institutions Float Held116.77%
Institutional HolderSharesReport Date
Blackrock Inc.2,747,4922026-03-31
Vanguard Capital Management LLC823,0642026-03-31
Soleus Capital Management, L.P.820,2432026-03-31
State Street Corporation771,5872026-03-31
Tang Capital Management, LLC707,5002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARSUFFagron N.V. $26.53 +0.00% 19.10 $1.95B 1.73%
BGMBGM Group Ltd. $0.30 +0.10% -1.81 $59.46M 0.00%
CASBFCanSino Biologics Inc. $2.60 +0.00% 1720.81 $908.20M 0.00%
DMPHFDermapharm Holding SE $53.00 +0.00% 16.91 $2.63B 1.91%
GTBIFGreen Thumb Industries Inc. $7.11 -0.70% 13.77 $1.65B 0.00%

About ANIP

ANIP stock trades at $82.63 with a market capitalization of $1.88B. The stock is valued at a price-to-earnings (P/E) ratio of 24.92, price-to-book of 3.48, price-to-sales of 2.04. Over the past 52 weeks the stock has ranged between $56.71 and $99.50, and currently trades 17.0% below its 52-week high.

On profitability, ANIP generates a return on equity (ROE) of 14.42%, above the typical market average, return on capital employed of 15.00%, an operating margin of 9.17%, a net profit margin of 9.71%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides